×
戻る Agenda
Session 3. Unlocking Potential : A Status Check on Multi-Reginal Clinical Trials for Global Drug Development
Session Chair(s)
Edana Loke
Director, JAPAC Regulatory Policy and Intelligence, AbbVie Pte Ltd, Singapore, Singapore
Martin Lim, MBA, MS
Co-Founder and CEO, ONWARD Health Research, Singapore
Speaker(s)
Martin Lim, MBA, MS
Co-Founder and CEO, ONWARD Health Research, Singapore
Romi Singh, PHD
Professor of Practice, Regulatory Sciences, Northeastern University, United States
I-Chun Lai, MD, MS
Senior Director, Division of Consultation, Center for Drug Evaluation, Taiwan, Taiwan
Dona Arlinda
Clinical Research Manager, INA-CRC, Ministry of Health (MOH) Indonesia, Indonesia
Bindoo Chahal, RPH
JAPAC Regulatory Affairs, Therapeutic Area Head, AbbVie Pte. Ltd., Singapore
Indri Rooslamiati Supriadi
Head of BB Binomika (Parent Organization of INA-CRC), Indonesia Ministry of Health (MOH), Indonesia